ID

13663

Descripción

A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00001567

Link

https://clinicaltrials.gov/show/NCT00001567

Palabras clave

Versiones (1)
  1. 24/2/16 24/2/16 -
Subido en

24 de febrero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hairy Cell Leukemia NCT00001567

Inglés

Eligibility Hairy Cell Leukemia NCT00001567

1 formularios  
Criteria
Descripción

Criteria

patients must have morphologically identifiable hairy cells in peripheral blood and bone marrow, or tissue biopsies with at least one of the following: 1) positive stain for the tartrate-resistant acid phosphatase 2) electron microscopy compatible with hairy cells.
Descripción

hairy cells, tartrate resistant acid phosphatase positive

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0333850
UMLS CUI [2]
C0297331
UMLS CUI [3]
C0013842
patients must be ambulatory with an expected survival greater than 16 weeks and be willing and able to give written informed consent.
Descripción

ambulatory patients, life expectancy, informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0002423
UMLS CUI [2]
C0023671
UMLS CUI [3]
C0021430
patients must have a disease that is assessable, defined by: 1) pancytopenia 2) bone marrow leukemic infiltrate 3) lymphadenopathy, splenomegaly, or hepatomegaly.
Descripción

assessable disease, definition

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0030312
UMLS CUI [2]
C0346979
UMLS CUI [3]
C0497156
UMLS CUI [4]
C0038002 | C0019209
patients must not require palliative chemotherapy, immunotherapy or hormonal therapy other than the treatment prescribed in this protocol.
Descripción

palliative therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0030231
patients must be tested for hepatitis b surface antigen within one week of entry into this study.
Descripción

hepatitis b surface antigen

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019168
no pregnant or lactating women. no fertile men and women, unless using effective contraception.
Descripción

pregnant or lactating, fertility, contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0015895
UMLS CUI [4]
C0700589
no patients with unstable angina. patients with class iii or iv cardiovascular disease may be entered only after medical clearance by a cardiology consultant.
Descripción

unstable angina, cardiovascular disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222
no patients with severe intercurrent infection or patients having had surgery within the past four weeks unless fully recovered.
Descripción

infection, prior surgery

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0543467
no patients with impaired renal function (serum creatinine greater than 1.8).
Descripción

renal function, creatinine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
no patients with impaired hepatic function (total bilirubin greater than 1.4).
Descripción

hepatic function, bilirubin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
no patients with serum calcium greater than 12 mg/dl.
Descripción

serum calcium

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0728876
no patients with a performance status less than or equal to 60% on the karnofsky scale.
Descripción

karnofsky

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
no patients who have had any prior (leukocyte or fibroblast) interferon therapy.
Descripción

interferon therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279030
no patients unable to carry out the treatment program.
Descripción

able to carry out treatment program

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1321605
no patients less than 20,000 per cu mm platelets and clinical bleeding disorder; both must be present for patient to be excluded.
Descripción

platelets and blood coagulation disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005821
UMLS CUI [2]
C0005779
Volver a la parte superior de la página

Similar models

Eligibility Hairy Cell Leukemia NCT00001567

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
hairy cells, tartrate resistant acid phosphatase positive
Item
patients must have morphologically identifiable hairy cells in peripheral blood and bone marrow, or tissue biopsies with at least one of the following: 1) positive stain for the tartrate-resistant acid phosphatase 2) electron microscopy compatible with hairy cells.
boolean
C0333850 (UMLS CUI [1])
C0297331 (UMLS CUI [2])
C0013842 (UMLS CUI [3])
ambulatory patients, life expectancy, informed consent
Item
patients must be ambulatory with an expected survival greater than 16 weeks and be willing and able to give written informed consent.
boolean
C0002423 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
C0021430 (UMLS CUI [3])
assessable disease, definition
Item
patients must have a disease that is assessable, defined by: 1) pancytopenia 2) bone marrow leukemic infiltrate 3) lymphadenopathy, splenomegaly, or hepatomegaly.
boolean
C0030312 (UMLS CUI [1])
C0346979 (UMLS CUI [2])
C0497156 (UMLS CUI [3])
C0038002 | C0019209 (UMLS CUI [4])
palliative therapy
Item
patients must not require palliative chemotherapy, immunotherapy or hormonal therapy other than the treatment prescribed in this protocol.
boolean
C0030231 (UMLS CUI [1])
hepatitis b surface antigen
Item
patients must be tested for hepatitis b surface antigen within one week of entry into this study.
boolean
C0019168 (UMLS CUI [1])
pregnant or lactating, fertility, contraceptive methods
Item
no pregnant or lactating women. no fertile men and women, unless using effective contraception.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0015895 (UMLS CUI [3])
C0700589 (UMLS CUI [4])
unstable angina, cardiovascular disease
Item
no patients with unstable angina. patients with class iii or iv cardiovascular disease may be entered only after medical clearance by a cardiology consultant.
boolean
C0007222 (UMLS CUI [1])
infection, prior surgery
Item
no patients with severe intercurrent infection or patients having had surgery within the past four weeks unless fully recovered.
boolean
C0009450 (UMLS CUI [1])
C0543467 (UMLS CUI [2])
renal function, creatinine
Item
no patients with impaired renal function (serum creatinine greater than 1.8).
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
hepatic function, bilirubin
Item
no patients with impaired hepatic function (total bilirubin greater than 1.4).
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
serum calcium
Item
no patients with serum calcium greater than 12 mg/dl.
boolean
C0728876 (UMLS CUI [1])
karnofsky
Item
no patients with a performance status less than or equal to 60% on the karnofsky scale.
boolean
C0206065 (UMLS CUI [1])
interferon therapy
Item
no patients who have had any prior (leukocyte or fibroblast) interferon therapy.
boolean
C0279030 (UMLS CUI [1])
able to carry out treatment program
Item
no patients unable to carry out the treatment program.
boolean
C1321605 (UMLS CUI [1])
platelets and blood coagulation disorder
Item
no patients less than 20,000 per cu mm platelets and clinical bleeding disorder; both must be present for patient to be excluded.
boolean
C0005821 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial